drugset / Trial / NCT07439796
A Study of ORN252 in Healthy Participants
NaSequentialOpen-labelBasic science
Summary
The purpose of this study is to assess the safety and tolerability of ORN252 in healthy adult participants.
Timeline
- Start
- 2026-03-16
- Primary completion
- 2026-12
- Completion
- 2027-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ORN252 | Other / unclassified | — | — |
Indications
No indication recorded.